Early Cognitive Interventions in Digital Format for Cancer Survivors (NCT07729969) | Clinical Trial Compass
RecruitingNot Applicable
Early Cognitive Interventions in Digital Format for Cancer Survivors
Spain110 participantsStarted 2026-06-08
Plain-language summary
The aim of this study is to evaluate the usability and effectiveness of two professionally supervised home-based cognitive training interventions as part of an early rehabilitation protocol for cancer-related cognitive impairment.
Participants will be randomized to one of the two intervention arms (computerized cognitive intervention or virtual reality cognitive intervention) or to the control group. Participants of the intervention groups will be assessed before and after the 10 weeks intervention or at equivalent time points for the control group. Comparisons between experimental and control participants, and between the participants in the two intervention arms, will be carried out to see which intervention is most effective and accepted.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients over 18 years of age diagnosed with cancer (stage I-III)
* Subjective complaints of cognitive functioning related to the diagnosis of cancer and/or cancer treatments
* Between 1-6 months after completion of chemotherapy treatment
* To have Wi-Fi and a computer/tablet
* To sign the informed consent form
Exclusion Criteria:
* Previous history of cancer diagnosis
* Anticipated change in cancer treatment/general medical treatment during the intervention period
* Previous diagnosis of cognitive impairment
* Diagnosis of other neurological or psychiatric diseases
* Diagnosis of severe untreated depression
* History of episodes of vertigo, epilepsy or seizures
* Currently undergoing or having undergone any other type of intervention aimed at improving cognitive functioning (e.g., CRCI workshops)
* Severe visual or hearing difficulties that may affect the performance of the intervention exercises
* Inability to speak, understand, read, and write Spanish correctly
* Failure to sign the informed consent form
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Perceived Cognitive Function
Timeframe: Baseline (before randomization and intervention), after completion of the 10-week intervention, and 1 year after completion of the intervention.